Arkolith/Insider Trading/BIOR/Form 4

Athyrium Opportunities Associates III GP LLC

Director, 10% OwnerBIORA THERAPEUTICS, INC. (BIOR) · full profile →Form 4 · filed Dec 20, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 18, 2023Grant(A)5.0M——5.0M
Dec 18, 2023Grant(A)10.4M——17.4M
Dec 18, 2023Disposed to issuer(D)53.5M——0
Dec 18, 2023Grant(A)7.0M——7.0M
Dec 18, 2023Grant(A)2.1M——2.1M

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-020668) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML